Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$10.50 USD
+0.50 (5.00%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $10.32 -0.18 (-1.71%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Earnings News For TNGX
-
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Tops Revenue Estimates
-
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
-
Earnings Preview: Tango Therapeutics, Inc. (TNGX) Q2 Earnings Expected to Decline
-
Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Misses Revenue Estimates
-
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
-
Will Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know
-
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
-
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Tops Revenue Estimates
-
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Misses Revenue Estimates
-
Tango Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
-
Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates
-
Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Highlights
-
Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release